Howard Shi PhD, President&CEO,Professor and doctoral supervisor
Postdoctoral fellow, Department of Pathology, Harvard Medical School
Ph.D., Biochemical and Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences.
Bachelor, Biochemistry, School of Life Sciences, Xiameng University.
Distinguished professor, doctoral supervisor and postdoctoral supervisor at the Beijing University of Traditional Chinese Medicine. Previous executive dean of the School of Life Sciences, Beijing University of Chinese Medicine and president of the Research Institute of Beijing University of Chinese Medicine in Shenzhen.
Mainly explore changing the molecular structure of CAR, enhance the specificity of antigen recognition and killing, and achieve the accuracy of CAR-T treatment.
With rich experience in business management, as founder Dr. Shi established the School of Life Sciences of Beijing University of Traditional Chinese Medicine, Shenzhen Research Institute of Beijing University of Traditional Chinese Medicine, Biotang Inc.(USA), Junjo Pharmaceuticals Co., LTD., Shenzhen Cell Valley and other companies have been operating.